https://www.selleckchem.com/pr....oducts/anlotinib-al3
After imaging, patient described symptoms of epigastric pain with elevated serum amylase and lipase levels, confirming diagnosis of regorafenib-induced pancreatitis, because patient had no other causative factors of pancreatitis. Physicians should be aware of rare and possibly clinically silent adverse effects of tyrosine kinase inhibitors, like acute pancreatitis, and recognize the 18F-FDG PET/CT findings to guide appropriate clinical management. A 55-year-old woman with multiple medical problems, including anuric, dialysis-de
Like
Comment
Share
